Novartis AG (NVS) is considered a long-term investment opportunity with strong operating performance

From Yahoo Finance: 2025-06-24 17:51:00

Novartis AG (NVS) shares were trading at $120.77 on June 12th, with trailing and forward P/E of 18.93 and 14.31 respectively. Novartis presents a long-term investment opportunity with strong operating performance, rising margins, and a robust pipeline. Management’s strategic decisions capitalize on the company’s competitive advantages and promising growth prospects, positioning NVS as an undervalued healthcare leader. Hedge funds’ interest in NVS has increased, but some AI stocks may offer higher returns with limited downside risk.



Read more at Yahoo Finance: Novartis AG (NVS): A Bull Case Theory